KLK10 and acute lymphoblastic leukemia: KLK10 represents a potential tumor suppressor, and its mRNA and protein expressions are downregulated in ALL and breast and prostate cancers (Roman-Gomez et al., 2004; Kioulafa et al., 2009; Olkhov-Mitsel et al., 2012).